Dr. Nagpal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Drive Cc2221
Stanford Advanced Medicine Center
Stanford, CA 94305Phone+1 650-725-8630Fax+1 650-498-4686
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 2006 - 2007
Perelman School of Medicine at the University of PennsylvaniaClass of 2004
Certifications & Licensure
CA State Medical License 2006 - 2025
IA State Medical License 2004 - 2011- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma Start of enrollment: 2016 Aug 01
- BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab Start of enrollment: 2017 Jan 04
- Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 129 citationsCentral Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyLouis B. Nabors, Jana Portnow, Manmeet Ahluwalia, Joachim Baehring, Henry Brem
Journal of the National Comprehensive Cancer Network. 2020-11-02 - 58 citationsMacrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in GlioblastomaReena Thomas, Seema Nagpal, Michael, Scott G. Soltys, Sophie Bertrand
Clinical Cancer Research. 2019-09-19 - 195 citationsCurrent State of Immunotherapy for Treatment of Glioblastoma.Tresa McGranahan, Kate Elizabeth Therkelsen, Sarah Ahmad, Seema Nagpal
Current Treatment Options in Oncology. 2019-02-21
Press Mentions
How COVID-19 Could Be Contributing to More Diabetes DiagnosesFebruary 9th, 2022- Parents Urged to Screen for Diabetes Symptoms After Link Found to COVID Infections in KidsJanuary 12th, 2022
- COVID-19 Causing Diabetes Among Some Severely Infected Patients, Studies FindNovember 28th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
